BRIGHT MINDS BIOSCIENCES INC (DRUG) Stock Cash Flow
NASDAQ:DRUG • CA10919W4056
Current stock price
71.62 USD
-0.66 (-0.91%)
At close:
71.62 USD
0 (0%)
After Hours:
| TTM (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -19.84M | -12.23M | -2.80M | -7.37M | -14.96M | |||
| Depreciation Amortization | 75.20K | 76.90K | 73.40K | 72.50K | 6.00K | |||
| Change In Working Capital | -322.80K | 555.00K | 39.80K | -941.70K | 724.10K | |||
| Other non cash items | 7.08M | 2.91M | 838.60K | 1.22M | 647.70K | |||
| OPERATING CASH FLOW | -13.01M | -8.69M | -1.85M | -7.02M | -13.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -102.40K | -100.20K | -89.70K | -86.10K | -7.20K | |||
| Stock Issued/Repurchased | 47.83M | 86.03M | 900.30K | 2.30M | 6.00M | |||
| Other Financing Activity | -812.50K | -360.10K | 0.00 | -27.00K | -800.00K | |||
| FINANCING CASH FLOW | 46.92M | 85.57M | 810.60K | 2.19M | 5.20M | |||
| Exchange Rate Effect | -2.75M | 312.60K | 11.70K | -45.40K | 258.80K | |||
| CHANGE IN CASH | 31.15M | 77.19M | -1.03M | -4.88M | -8.13M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.01M | -8.69M | -1.85M | -7.02M | -13.59M | |||
| FREE CASH FLOW | -13.01M | -8.69M | -1.85M | -7.02M | -13.59M | |||
All data in CAD